- Home
- BIAF vs ISPC Comparison
BIAF vs ISPC Comparison
Compare BIAF & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIAF | ISPC |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 3.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BIAF | ISPC |
|---|---|---|
| Price | $1.62 | $3.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 319.7K | ★ 2.7M |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | $20.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $0.10 |
| 52 Week High | $13.50 | $6.77 |
Technical Indicators
Market Signals| Indicator | BIAF | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 51.17 |
| Support Level | $1.23 | $0.37 |
| Resistance Level | $1.79 | $6.77 |
| Average True Range (ATR) | 0.18 | 0.49 |
| MACD | -0.02 | -0.31 |
| Stochastic Oscillator | 20.37 | 5.92 |
Price Performance
Historical ComparisonAbout BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.